BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36455397)

  • 21. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy.
    Crabtree TD; Puri V; Robinson C; Bradley J; Broderick S; Patterson GA; Liu J; Musick JF; Bell JM; Yang M; Meyers BF
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1183-1191; discussion 1191-2. PubMed ID: 24507980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis.
    Zheng X; Schipper M; Kidwell K; Lin J; Reddy R; Ren Y; Chang A; Lv F; Orringer M; Spring Kong FM
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):603-11. PubMed ID: 25052562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
    Chi A; Fang W; Sun Y; Wen S
    JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of stereotactic body radiation therapy volume on surgical patient selection, short-term survival, and long-term survival in early-stage non-small cell lung cancer.
    Till BM; Mack S; Whitehorn G; Rahman U; Thosani D; Grenda T; Evans NR; Okusanya O
    J Thorac Cardiovasc Surg; 2023 Feb; 165(2):471-479. PubMed ID: 36088141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.
    Tandberg DJ; Tong BC; Ackerson BG; Kelsey CR
    Cancer; 2018 Feb; 124(4):667-678. PubMed ID: 29266226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
    Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
    Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies.
    Viani GA; Gouveia AG; Yan M; Matsuura FK; Moraes FY
    J Bras Pneumol; 2022; 48(3):e20210390. PubMed ID: 35508065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non-Small-Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy.
    Liu J; Hui C; Ladbury C; Waddington T; Erhunmwunsee L; Raz D; Kim J; Salgia R; Chenery S; Pearlstein D; Schwer A; Amini A
    Clin Lung Cancer; 2021 Sep; 22(5):e678-e683. PubMed ID: 33712362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.
    Ackerson BG; Tong BC; Hong JC; Gu L; Chino J; Trotter JW; D'Amico TA; Torok JA; Lafata K; Chang C; Kelsey CR
    Lung Cancer; 2018 Nov; 125():185-191. PubMed ID: 30429018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.
    Samson P; Keogan K; Crabtree T; Colditz G; Broderick S; Puri V; Meyers B
    Lung Cancer; 2017 Jan; 103():6-10. PubMed ID: 28024698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?
    Onishi H; Shirato H; Nagata Y; Hiraoka M; Fujino M; Gomi K; Karasawa K; Hayakawa K; Niibe Y; Takai Y; Kimura T; Takeda A; Ouchi A; Hareyama M; Kokubo M; Kozuka T; Arimoto T; Hara R; Itami J; Araki T
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1352-8. PubMed ID: 20638194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future.
    Hamaji M
    Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):692-696. PubMed ID: 31667707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
    Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence?
    Guckenberger M
    Expert Rev Anticancer Ther; 2015 May; 15(5):525-30. PubMed ID: 25761997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of efficacy of stereotactic body radiotherapy and thoracoscopic surgery in the treatment of early-stage non-small cell lung cancer.
    Li X; Niu C; Chen Q; Chen X
    J BUON; 2020; 25(3):1497-1503. PubMed ID: 32862596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.
    Chi A; Chen H; Wen S; Yan H; Liao Z
    Radiother Oncol; 2017 Jun; 123(3):346-354. PubMed ID: 28545956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
    Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
    Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.